Results 131 to 140 of about 3,564,161 (186)

Studies of FLT3 mutations in paired presentation and relapse samples from patients with acute myeloid leukemia: implications for the role of FLT3 mutations in leukemogenesis, minimal residual disease detection, and possible therapy with FLT3 inhibitors [PDF]

open access: yes, 2002
FLT3 mutations, either internal tandem duplications (ITDs) or aspartate residue 835 (D835) point mutations, are present in approximately one third of patients with acute myeloid leukemia (AML) and have been associated with an increased relapse rate.
Kottaridis, P.D.   +5 more
core  

Promyelocytic leukemia protein in mesenchymal stem cells is essential for leukemia progression. [PDF]

open access: yesAnn Hematol, 2018
de Alvarenga EC   +5 more
europepmc   +1 more source

Promyelocytic Leukemia Protein (PML) Requirement for Interferon-induced Global Cellular SUMOylation. [PDF]

open access: yesMol Cell Proteomics, 2018
Maroui MA   +5 more
europepmc   +1 more source

Promyelocytic Leukemia Protein (PML) Regulates Stem Cell Pluripotency Through Novel Sumoylation Targets. [PDF]

open access: yesInt J Mol Sci
Spanou S   +9 more
europepmc   +1 more source

Promyelocytic leukemia protein (PML) controls breast cancer cell proliferation by modulating Forkhead transcription factors. [PDF]

open access: yesMol Oncol, 2019
Sachini N   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy